Winnow Wealth LLC Sells 29,064 Shares of Centene Corporation $CNC

Winnow Wealth LLC reduced its stake in shares of Centene Corporation (NYSE:CNC) by 95.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,503 shares of the company’s stock after selling 29,064 shares during the period. Winnow Wealth LLC’s holdings in Centene were worth $63,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in CNC. Baird Financial Group Inc. purchased a new position in shares of Centene during the 1st quarter valued at about $236,000. Sivia Capital Partners LLC increased its holdings in shares of Centene by 80.0% in the second quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock worth $527,000 after buying an additional 4,315 shares during the period. CW Advisors LLC increased its stake in Centene by 20.3% in the 2nd quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock worth $264,000 after purchasing an additional 820 shares during the period. NewEdge Advisors LLC increased its stake in shares of Centene by 6.1% in the second quarter. NewEdge Advisors LLC now owns 44,945 shares of the company’s stock worth $2,440,000 after buying an additional 2,582 shares during the period. Finally, Treasurer of the State of North Carolina grew its holdings in Centene by 0.4% in the 2nd quarter. Treasurer of the State of North Carolina now owns 231,938 shares of the company’s stock worth $12,590,000 after acquiring an additional 967 shares during the last quarter. Institutional investors own 93.63% of the company’s stock.

Analyst Ratings Changes

CNC has been the topic of a number of research analyst reports. Barclays boosted their price target on Centene from $63.00 to $75.00 and gave the company an “overweight” rating in a report on Tuesday, May 26th. Bank of America upped their target price on Centene from $72.00 to $74.00 and gave the company a “buy” rating in a report on Thursday, June 4th. Raymond James Financial set a $60.00 price target on Centene in a research note on Wednesday, April 29th. UBS Group reissued a “neutral” rating and set a $61.00 price objective (up from $55.00) on shares of Centene in a research report on Friday, May 22nd. Finally, Wells Fargo & Company upped their price objective on shares of Centene from $44.00 to $56.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Centene currently has a consensus rating of “Hold” and an average price target of $60.24.

Centene Trading Up 1.8%

NYSE CNC opened at $66.23 on Wednesday. The firm has a market capitalization of $32.70 billion, a PE ratio of -5.04, a P/E/G ratio of 0.51 and a beta of 1.09. The stock’s 50 day moving average is $49.52 and its 200 day moving average is $43.77. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $66.55. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.76.

Centene (NYSE:CNC) last posted its quarterly earnings data on Tuesday, April 28th. The company reported $3.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.23 by $1.14. Centene had a positive return on equity of 5.57% and a negative net margin of 3.25%.The business had revenue of $49.94 billion during the quarter, compared to the consensus estimate of $47.53 billion. During the same quarter in the prior year, the company earned $2.90 earnings per share. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. Research analysts forecast that Centene Corporation will post 3.45 earnings per share for the current fiscal year.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.